New Global Cancer Research Initiative Launches
An NYU Langone, Technion joint research venture focuses on melanoma and mesothelioma in first projects with funding from the Perlmutters.
New Guidelines for Surgical Management of Thyroid Disease
NYU Langone’s Dr. Kepal N. Patel is the lead author of new guidelines establishing best practices for surgically managing adult thyroid disease.
New Guidelines for Treating First Seizure
A research team that included NYU Langone experts reported new evidence on how to best treat a first seizure, which affects one in 10 people.
New Hearing Loss Program Launches for Immigrant Families
NYU Langone launches new hearing loss and screening program for underserved immigrant families to advance health equity.
New Heart Transplant Program Addresses Growing Demand
Heart failure specialist Dr. Alex Reyentovich leads NYU Langone’s new Heart Transplant Program.
New Hematology & Medical Oncology Chief in Sunset Park Named
NYU Langone names Dr. Nina D’Abreo as the chief of the Division of Hematology and Medical Oncology at Perlmutter Cancer Center—Sunset Park.
New Hope for Patients Who Have Lung Cancer
NYU Winthrop Hospital offer immunotherapies for people who have lung cancer.
New Hospital Pavilion with Pediatric Hospital Facility Opens
NYU Langone adds to New York City’s healthcare space with the Helen L. and Martin S. Kimmel Pavilion and Hassenfeld Children’s Hospital.
New Hybrid Treatment Forces Cancer Cells to Starve
An NYU Langone study shows that the combination of a drug and a protein fragment prevents the growth of multiply myeloma cancer cells in mice.
New Imaging Sequences Surface Hard-to-Detect Microadenomas
New Imaging Sequences Surface Hard-to-Detect MicroadenomasWhen microadenomas are correctly identified and localized preoperatively in the pituitary gland, a minimally ...